Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation
Cushing’s syndrome is associated with increased morbidity and mortality. Although surgery is the first-line treatment, drugs can still play a role as an ancillary treatment to be employed while waiting for surgery, after unsuccessful operation or in patients unsuitable for surgery. We were asked to...
Main Authors: | Roberto Attanasio, Liana Cortesi, Daniela Gianola, Claudia Vettori, Fulvio Sileo, Roberto Trevisan |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2017-03-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-16-0140 |
Similar Items
-
Pasireotide: A new option for treatment of acromegaly
by: Filiz Eksi Haydardedeoglu, et al.
Published: (2020-06-01) -
Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric study
by: Vittoria Favero, et al.
Published: (2024-02-01) -
Management and Medical Therapy of Mild Hypercortisolism
by: Vittoria Favero, et al.
Published: (2021-10-01) -
Effects of Trilostane on urinary Catecholamines and their metabolites in dogs with Hypercortisolism
by: Nadja Sieber-Ruckstuhl, et al.
Published: (2017-09-01) -
Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside
by: Vittoria Favero, et al.
Published: (2022-01-01)